Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Ursodeoxycholic acid manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

ursodeoxycholic acid

Tablets 300 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18273

Manufacturer usually replies in 5 days

ursodeoxycholic acid

Tablets 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17459
This pharmaceutical company is a rapidly growing force in the global healthcare market, specializing in high-quality, affordable medications. They boast a diverse product portfolio encompassing prescription drugs, over-the-counter medications, and supplements, targeting key therapy areas like anti-Alzheimer's, asthma, diabetes, and cardiovascular health. The company holds WHO-GMP certifications and international approvals, underscoring their commitment to quality and regulatory compliance. Their manufacturing facilities are equipped with state-of-the-art technology, ensuring the production of safe and effective medicines. They distribute their products widely across multiple regions, including South East Asia and the Middle East, leveraging a robust network of distributors and consignees. Their mission is to provide accessible and affordable healthcare solutions worldwide, aiming to be a trusted partner for high-quality pharmaceuticals globally.

Manufacturer usually replies in 2 days

ursodeoxycholic acid

Tablets 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17145
The company is an ISO 9001:2015 certified pharmaceutical group with a strong presence across South Asia and aims to expand into international markets. Specializing in a diverse range of healthcare products, including capsules, eye and ear drops, injectables, mouthwash, protein powders, syrups, and tablets, the company is committed to quality and innovation. Supported by a team of experienced professionals and consultants, the company focuses on human resource development through regular training and skill enhancement programs, ensuring a high-performing workforce capable of navigating the challenges of globalization and technological advancement.

Manufacturer usually replies in 53 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Ursodeoxycholic acid is a bile acid used to treat gallstones as well as to treat and prevent the progression of cystic fibrosis-related liver disorders. Suppliers of ursodeoxycholic acid market it in the form of 150mg, 250mg and 500mg oral tablets and capsules. The market for ursodeoxycholic acid is relatively competitive, populated with numerous manufacturing companies and suppliers. The largest manufacturers of ursodeoxycholic acid market globally are companies Mitsubishi Tanabe Pharma, Daewoong Chemical, and PharmaZell, Glenmark Pharmaceuticals, Dipharma Francis, Errengierre, and Grindeks. Ursodeoxycholic acid suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified ursodeoxycholic acid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 50 (250mg) tablets of ursodeoxycholic acid fall into an approximate range of 12,00 EUR to 15,00 EUR, whereas the equivalent amount of 500mg tablets cost from 25,00 EUR to 30,00 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.